Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease

Table 1

Characteristics among groups before IPW. AP, antiplatelet group; AC, anticoagulant group; AC-AP, antiplatelet-anticoagulation group; and non-AT, the group that did not receive antithrombotic treatment.

Characteristics	Non-AT group	AP group	AC group	AC-AP group	P value
Age (median, IQR)	75.5 (66.8, 83.3)	73.6 (66.5, 80.7)	74.3 (62.5, 83)	73.7 (65.4, 81.2)	0.196
Gender (n, %)					0.608
Female	89 (43.4)	57 (42.5)	80 (49.1)	128 (46.7)
Male	116 (56.6)	77 (57.5)	83 (50.9)	146 (53.3)
CRRT (n, %)					0.324
No	198 (96.6)	130 (97)	152 (93.3)	259 (94.5)
Yes	7 (3.4)	4 (3)	11 (6.7)	15 (5.5)
Alcoholism (n, %)					0.054
No	199 (97.1)	128 (95.5)	150 (92)	266 (97.1)
Yes	6 (2.9)	6 (4.5)	13 (8)	8 (2.9)
Heart failure (n, %)					0.537
No	94 (45.9)	65 (48.5)	76 (46.6)	114 (41.6)
Yes	111 (54.1)	69 (51.5)	87 (53.4)	160 (58.4)
Hypertension					0.024
No	67 (32.7)	27 (20.1)	47 (28.8)	62 (22.6)
Yes	138 (67.3)	107 (79.9)	116 (71.2)	212 (77.4)
Diabetes (n, %)					0.319
No	104 (50.7)	68 (50.7)	93 (57.1)	131 (47.8)
Yes	101 (49.3)	66 (49.3)	70 (42.9)	143 (52.2)
Obesity (n, %)					0.175
No	193 (94.1)	123 (91.8)	156 (95.7)	248 (90.5)
Yes	12 (5.9)	11 (8.2)	7 (4.3)	26 (9.5)
Renal failure (n, %)					0.274
No	114 (55.6)	88 (65.7)	97 (59.5)	156 (56.9)
Yes	91 (44.4)	46 (34.3)	66 (40.5)	118 (43.1)
Liver disease (n, %)					0.573
No	190 (92.7)	123 (91.8)	145 (89)	253 (92.3)
Yes	15 (7.3)	11 (8.2)	18 (11)	21 (7.7)
Sofa (median, IQR)	4 (3, 6)	6 (4, 7)	5 (3.5, 7)	5 (3, 7.8)	0.013
INR (median, IQR)	1.2 (1.1, 1.5)	1.2 (1.1, 1.6)	1.3 (1.1, 1.8)	1.2 (1.1, 1.6)	0.668
PT (median, IQR)	13.9 (12.9, 16.1)	14.3 (12.9, 16.7)	14.5 (12.9, 19.1)	13.9 (12.8, 16.8)	0.398
PPT (median, IQR)	30.1 (26.5, 36)	32 (26.4, 39.1)	30.8 (26.9, 36.9)	30.4 (26.4, 38)	0.561
SpO2 (median, IQR)	97.2 (96, 98.5)	97.9 (96.5, 98.8)	97.7 (96.4, 98.7)	97.6 (96.2, 98.7)	0.086